Christopher Heery - Net Worth and Insider Trading
Christopher Heery Net Worth
The estimated net worth of Christopher Heery is at least $731,040 dollars as of 2024-12-26. Christopher Heery is the CHIEF MEDICAL OFFICER of Arcellx Inc and owns about 9,278 shares of Arcellx Inc (ACLX) stock worth over $730,643. Christopher Heery is also the Chief Medical Officer of Precision BioSciences Inc and owns about 83 shares of Precision BioSciences Inc (DTIL) stock worth over $398. Details can be seen in Christopher Heery's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Christopher Heery has not made any transactions after 2024-09-05 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Christopher Heery
Christopher Heery Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Christopher Heery owns 2 companies in total, including Precision BioSciences Inc (DTIL) , and Arcellx Inc (ACLX) .
Click here to see the complete history of Christopher Heery’s form 4 insider trades.
Insider Ownership Summary of Christopher Heery
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| DTIL | Precision BioSciences Inc | 2019-12-19 | Chief Medical Officer |
| ACLX | Arcellx Inc | 2024-09-05 | Chief Medical Officer |
Christopher Heery Latest Holdings Summary
Christopher Heery currently owns a total of 2 stocks. Among these stocks, Christopher Heery owns 9,278 shares of Arcellx Inc (ACLX) as of September 5, 2024, with a value of $730,643 and a weighting of 99.95%. Christopher Heery also owns 83 shares of Precision BioSciences Inc (DTIL) as of December 19, 2019, with a value of $398 and a weighting of 0.05%.
Latest Holdings of Christopher Heery
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ACLX | Arcellx Inc | 2024-09-05 | 9,278 | 78.75 | 730,643 |
| DTIL | Precision BioSciences Inc | 2019-12-19 | 83 | 4.79 | 398 |
Holding Weightings of Christopher Heery
Christopher Heery Form 4 Trading Tracker
According to the SEC Form 4 filings, Christopher Heery has made a total of 26 transactions in Arcellx Inc (ACLX) over the past 5 years, including 0 buys and 26 sells. The most-recent trade in Arcellx Inc is the sale of 3,421 shares on September 5, 2024, which brought Christopher Heery around $239,538.
According to the SEC Form 4 filings, Christopher Heery has made a total of 0 transactions in Precision BioSciences Inc (DTIL) over the past 5 years. The most-recent trade in Precision BioSciences Inc is the acquisition of 83 shares on December 19, 2019, which cost Christopher Heery around $30,019.
Insider Trading History of Christopher Heery
- 1
Christopher Heery Trading Performance
GuruFocus tracks the stock performance after each of Christopher Heery's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Christopher Heery is -52.69%. GuruFocus also compares Christopher Heery's trading performance to market benchmark return within the same time period. The performance of stocks bought by Christopher Heery within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Christopher Heery's insider trading performs compared to the benchmark.
Performance of Christopher Heery
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -11.66 | | | | | |
| Relative Return to S&P 500(%) | -15.54 | | | | | |
Christopher Heery Ownership Network
Christopher Heery Owned Company Details
What does Precision BioSciences Inc do?
Who are the key executives at Precision BioSciences Inc?
Christopher Heery is the Chief Medical Officer of Precision BioSciences Inc. Other key executives at Precision BioSciences Inc include Interim CFO John Alexander Kelly , director & President and CEO Michael Amoroso , and General Counsel Dario Scimeca .
Precision BioSciences Inc (DTIL) Insider Trades Summary
Over the past 18 months, Christopher Heery made no insider transaction in Precision BioSciences Inc (DTIL). Other recent insider transactions involving Precision BioSciences Inc (DTIL) include a net sale of 38,263 shares made by Dario Scimeca , a net sale of 266,953 shares made by Michael Amoroso , and a net sale of 28,204 shares made by J. Jefferson Smith .
In summary, during the past 3 months, insiders sold 3,600 shares of Precision BioSciences Inc (DTIL) in total and bought 3,000 shares, with a net sale of 600 shares. During the past 18 months, 17,865 shares of Precision BioSciences Inc (DTIL) were sold and 6,000 shares were bought by its insiders, resulting in a net sale of 11,865 shares.
Precision BioSciences Inc (DTIL)'s detailed insider trading history can be found in Insider Trading Tracker table.
Precision BioSciences Inc Insider Transactions
Christopher Heery Mailing Address
Above is the net worth, insider trading, and ownership report for Christopher Heery. You might contact Christopher Heery via mailing address: C/o Precision Biosciences, Inc., 302 E. Pettigrew Street, Suite A-100, Durham Nc 27701.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
